A catalyst don’t appear in the overall stoichiometry of the reaction it catalyzes, but it must appear in at least one of the elementary reactions in the mechanism for the catalyzed reaction. 1038-95-5, Name is Tri-p-tolylphosphine, molecular formula is C21H21P. In a Patent，once mentioned of 1038-95-5, category: chiral-phosphine-ligands
The present invention relates to the use of silver(l) monophosphine complexes as Active Pharmaceutical Ingredients (API’s), including anticancer agents, for the treatment, diagnosis and/or prevention of cancer. The present invention also relates to pharmaceutical compositions containing such complexes and further extends to a method of treating or diagnosing a subject/patient suffering from cancer.
Sometimes chemists are able to propose two or more mechanisms that are consistent with the available data.category: chiral-phosphine-ligands, If a proposed mechanism predicts the wrong experimental rate law, however, the mechanism must be incorrect.Welcome to check out more blogs about 1038-95-5, in my other articles.
Reference：
Phosphine ligand,
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate